Expressions and prognostic values of the E2F transcription factors in human breast carcinoma

References

• DegregoriJJohnsonDGDistinct and Overlapping Roles for E2F Family Members in Transcription, Proliferation and ApoptosisCurr Mol Med20066773974817100600
   PubMed Web of Science ®Google Scholar
• HollernDPHoneysettJCardiffRDAndrechekERThe E2F transcription factors regulate tumor development and metastasis in a mouse model of metastatic breast cancerMol Cell Biol201434173229324324934442
   PubMed Web of Science ®Google Scholar
• AndrechekERHER2/Neu tumorigenesis and metastasis is regulated by E2F activator transcription factorsOncogene201534221722524362522
   PubMed Web of Science ®Google Scholar
• AttwoollCLazzerini DenchiEHelinKThe E2F family: specific functions and overlapping interestsEmbo J200423244709471615538380
   PubMed Web of Science ®Google Scholar
• TorreLABrayFSiegelRLGlobal cancer statistics, 2012CA Cancer J Clin20156528710825651787
   PubMed Web of Science ®Google Scholar
• OnitiloAAEngelJMGreenleeRTMukeshBNBreast cancer subtypes based on ER/PR and Her2 expression: comparison of clinicopathologic features and survivalClin Med Res200971–241319574486
   PubMedGoogle Scholar
• VerlindenLvanden BemptIEelenGThe E2F-regulated gene Chk1 is highly expressed in triple-negative estrogen receptor/progesterone receptor/HER-2 breast carcinomasCancer Res200767146574658117638866
   PubMed Web of Science ®Google Scholar
• JohnsonJThijssenBMcdermottUTargeting the RB-E2F pathway in breast cancerOncogene201635374829483526923330
   PubMed Web of Science ®Google Scholar
• ChenHZTsaiSYLeoneGEmerging roles of E2Fs in cancer: an exit from cell cycle controlNat Rev Cancer200991178579719851314
   PubMed Web of Science ®Google Scholar
• PolanowskaJLe CamLOrsettiBHuman E2F5 gene is oncogenic in primary rodent cells and is amplified in human breast tumorsGenes Chromosomes Cancer200028112613010738311
   PubMed Web of Science ®Google Scholar
• UmemuraSShiraneMTakekoshiSOverexpression of E2F-5 correlates with a pathological basal phenotype and a worse clinical outcomeBr J Cancer2009100576477119259095
   PubMed Web of Science ®Google Scholar
• OberleyMJInmanDRFarnhamPJE2F6 negatively regulates BRCA1 in human cancer cells without methylation of histone H3 on lysine 9J Biol Chem200327843424664247612909625
   PubMed Web of Science ®Google Scholar
• YangWWWangZHZhuYYangHTE2F6 negatively regulates ultraviolet-induced apoptosis via modulation of BRCA1Cell Death Differ200714480781717096023
   PubMed Web of Science ®Google Scholar
• ChuJZhuYLiuYE2F7 overexpression leads to tamoxifen resistance in breast cancer cells by competing with E2F1 at miR-15a/16 promoterOncotarget2015631319443195726397135
   PubMedGoogle Scholar
• YeLGuoLHeZUpregulation of E2F8 promotes cell proliferation and tumorigenicity in breast cancer by modulating G1/S phase transitionOncotarget20167172375726992224
   PubMedGoogle Scholar
• SealfonSCChuTTRNA and DNA microarraysMethods Mol Biol201167167133420967621
   PubMedGoogle Scholar
• RhodesDRYuJShankerKONCOMINE: a cancer microarray database and integrated data-mining platformNeoplasia2004611615068665
   PubMed Web of Science ®Google Scholar
• RestJSWilkinsOYuanWPuruggananMDGurevitchJMeta-analysis and meta-regression of transcriptomic responses to water stress in ArabidopsisPlant J201685454856026756945
   PubMed Web of Science ®Google Scholar
• JézéquelPCamponeMGouraudWbc-GenExMiner: an easy-to-use online platform for gene prognostic analyses in breast cancerBreast Cancer Res Treat2012131376577521452023
   PubMed Web of Science ®Google Scholar
• JézéquelPFrénelJSCampionLbc-GenExMiner 30: new mining module computes breast cancer gene expression correlation analysesDatabase (Oxford)20132013bas06023325629
   PubMedGoogle Scholar
• GaoJAksoyBADogrusozUIntegrative analysis of complex cancer genomics and clinical profiles using the cBioPortalSci Signal20136269pl123550210
   PubMed Web of Science ®Google Scholar
• CeramiEGaoJDogrusozUThe cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics dataCancer Discov20122540140422588877
   PubMed Web of Science ®Google Scholar
• PereiraBChinSFRuedaOMThe somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapesNat Commun201671147927161491
   PubMed Web of Science ®Google Scholar
• GyőrffyBSurowiakPBudcziesJLánczkyAOnline survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancerPLoS One2013812e8224124367507
   PubMed Web of Science ®Google Scholar
• GyörffyBLanczkyAEklundACAn online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patientsBreast Cancer Res Treat2010123372573120020197
   PubMed Web of Science ®Google Scholar
• LánczkyANagyÁBottaiGmiRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patientsBreast Cancer Res Treat2016160343944627744485
   PubMed Web of Science ®Google Scholar
• LiQBirkbakNJGyorffyBSzallasiZEklundACJetset: selecting the optimal microarray probe set to represent a geneBMC Bioinformatics201112147447722172014
   PubMedGoogle Scholar
• CurtisCShahSPChinSFThe genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroupsNature2012486740334635222522925
   PubMed Web of Science ®Google Scholar
• LeeMRivera-RiveraYMorenoCSSaavedraHIThe E2F activators control multiple mitotic regulators and maintain genomic integrity through Sgo1 and BubR1Oncotarget20178447764929100415
   PubMedGoogle Scholar
• WuLde BruinAWangHSelective roles of E2Fs for ErbB2- and Myc-mediated mammary tumorigenesisOncogene201534111912824276244
   PubMed Web of Science ®Google Scholar
• VuaroqueauxVUrbanPLabuhnMLow E2F1 transcript levels are a strong determinant of favorable breast cancer outcomeBreast Cancer Res200793R3317535433
   PubMed Web of Science ®Google Scholar
• ZhaoYXLiuHCYingWYmicroRNA372 inhibits proliferation and induces apoptosis in human breast cancer cells by directly targeting E2F1Mol Med Rep20171668069807528944922
   PubMed Web of Science ®Google Scholar
• FujiwaraKYuwanitaIHollernDPPrediction and genetic demonstration of a role for activator E2Fs in Myc-induced tumorsCancer Res20117151924193221245101
   PubMed Web of Science ®Google Scholar
• Nguyen-VuTVedinLLLiuKLiver × receptor ligands disrupt breast cancer cell proliferation through an E2F-mediated mechanismBreast Cancer Res2013153R5123809258
   PubMed Web of Science ®Google Scholar
• LeeMOprea-IliesGSaavedraHISilencing of E2F3 suppresses tumor growth of Her2+ breast cancer cells by restricting mitosisOncotarget2015635373163733426512919
   PubMedGoogle Scholar
• VimalaKSundarrajSSujithaMVKannanSCurtailing overexpression of E2F3 in breast cancer using siRNA (E2F3)-based gene silencingArch Med Res201243641542222960857
   PubMed Web of Science ®Google Scholar
• CabelloPPinedaBTormoELluchAErolesPThe Antitumor Effect of Metformin Is Mediated by miR-26a in Breast CancerInt J Mol Sci20161781298
   PubMed Web of Science ®Google Scholar
• LiLXieXLuoJTargeted expression of miR-34a using the T-VISA system suppresses breast cancer cell growth and invasionMol Ther201220122326233423032974
   PubMed Web of Science ®Google Scholar
• RakhaEAPinderSEPaishECRobertsonJFEllisIOExpression of E2F-4 in invasive breast carcinomas is associated with poor prognosisJ Pathol2004203375476115221934
   PubMed Web of Science ®Google Scholar
• XuHFeiDZongSFanZMicroRNA-154 inhibits growth and invasion of breast cancer cells through targeting E2F5Am J Transl Res2016862620263027398145
   PubMed Web of Science ®Google Scholar